← Back to Merkel Cell Carcinoma

Follow-Up Care and Monitoring for Recurrence After Merkel Cell Carcinoma

Visit schedules, scans, and what to watch for after treatment

Medically reviewed by Dr. Steven Q. Wang, MDLast reviewed

Bring a printable list of questions to your appointment, or share this page with someone who needs it.

Download printable checklist (PDF)

Introduction

Merkel cell carcinoma (MCC) recurs more often than most skin cancers — in one large prospective study, about 40% of patients had a recurrence within five years — and the great majority of those recurrences happen in the first three years. That pattern shapes follow-up: visits are frequent and front-loaded, with imaging and, for some people, a blood test layered on top of a careful physical exam.

This guide describes what a typical surveillance schedule looks like, what each test is checking for, and the signs that should prompt a call between visits.

Have Questions?

Ask questions and get clear, trusted answers — instantly.

Chat with the Navigator

A Typical Surveillance Schedule

Exact timing is individualized by stage, immune status, and how the cancer behaved, but guideline-based schedules generally look like this:

  • •Years 1–3: Clinic visit with full skin and lymph node exam every 3–6 months.
  • •Years 4–5 and beyond: Visits every 6–12 months, continuing long term.
  • •Higher-risk patients (node-positive, larger tumors, immunosuppressed) are seen at the shorter end of those intervals and have more imaging.

What Each Part of Follow-Up Checks

Physical examination

The cornerstone of MCC surveillance. Your clinician inspects the original tumor site and the scar, the skin between the tumor and its draining lymph nodes (looking for "in-transit" nodules), the lymph node basins, and the rest of your skin for new primary cancers. Most recurrences are first found this way.

Imaging

People with node-positive or higher-stage disease usually have periodic PET/CT or CT during the first 2–3 years to catch spread that cannot be felt. Routine imaging is often not recommended for low-risk, node-negative disease, where the harms of frequent scans can outweigh the benefit. Lymph node ultrasound is sometimes used for patients who did not have a sentinel node biopsy.

Merkel cell polyomavirus antibody test

If your tumor is virus-positive and you produce antibodies to the viral T antigen, that antibody level can be measured at baseline and then every few months. A rising titer often precedes a visible recurrence and can prompt earlier scanning; a persistently low or falling titer is reassuring. It is only useful in the subset of patients who are antibody-positive to begin with. See Merkel cell polyomavirus and immune suppression.

Skin self-exams between visits

Check the treated area, the path toward the nearby lymph nodes, and those node areas once a month. Report any new firm bump, a lump under the skin, swelling, or a rapidly changing spot without waiting for the next appointment.

Call Your Team If You Notice

  • •A new lump or firm nodule near the original tumor or its scar
  • •Swelling or a palpable lump in the armpit, groin, or neck
  • •Small skin nodules appearing along the line between the tumor site and the lymph nodes
  • •Unexplained weight loss, persistent pain, cough, or fatigue
  • •Any new fast-growing spot elsewhere on your skin

Recurrences caught early — while still local or regional — can often be treated with surgery, radiation, or immunotherapy. Locoregional recurrence still warrants prompt, aggressive treatment because it can progress quickly.

What to Ask Your Doctor

Download printable checklist (PDF)
  1. Given my stage, how often should I be seen, and for how many years?
  2. Will I have scheduled imaging? Which scans, how often, and for how long?
  3. Was my tumor virus-positive, and can I use the antibody blood test to help monitor for recurrence?
  4. Which clinician "owns" my surveillance — dermatology, surgical oncology, or medical oncology?
  5. Exactly what should I check at home, and how do I reach you quickly if I find something?
  6. Does my immune status change any of the above?

Conclusion

Follow-up for MCC is deliberately intensive in the first three years because that is when nearly all recurrences appear. A careful physical exam is the most valuable tool, supported by risk-based imaging and, for virus-positive patients, an antibody blood test. Your own monthly checks fill the gaps between visits.

Know your schedule, know what you are watching for, and know how to reach your team fast — early detection of a recurrence keeps the most treatment options open.

Sources

Clinical Guidelines & Peer-Reviewed Literature

  • McEvoy AM, Lachance K, Hippe DS, et al. Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis. JAMA Dermatol. 2022;158(4):382-389. PubMed
  • Grotz TE, Tarantola TI, Otley CC, et al. Natural history of Merkel cell carcinoma following locoregional recurrence. Ann Surg Oncol. 2012;19(8):2556-2562. PubMed
  • Schmults CD, Blitzblau R, Aasi SZ, et al. NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024. J Natl Compr Canc Netw. 2024;22(1D):e240002. PubMed
  • Coggshall K, Tello TL, North JP, Yu SS. Merkel cell carcinoma: An update and review: Pathogenesis, diagnosis, and staging. J Am Acad Dermatol. 2018;78(3):433-442. PubMed

Patient Resources

Disclaimer: Educational only. Not a substitute for professional medical advice. Always consult your dermatologist or oncologist about your personal diagnosis and treatment plan.

Still Have Questions?

Chat with our AI guide for personalized information about Merkel cell carcinoma

Chat with the Navigator